European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

MT Newswires Live
10/02

European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.59% to 1,883.71 on the S&P Europe Select ADR Index, which has shed close to 2% for the week so far.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which rose 3.1% and 2.9%. respectively. They were followed by semiconductor company Sequans Communications (SQNS) and telecommunications company Ericsson (ERIC), which were up 2.7% and 1.6%, respectively.

The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and biopharmaceutical company DBV Technologies (DBVT), which fell 6.1% and 2.7%, respectively. They were followed by pharmaceutical company Sanofi (SNY) and biopharmaceutical company argenx (ARGX), which were down 1.9% and 1.5%, respectively.

The gainers from the UK were led by telecommunications operator Vodafone Group (VOD) and utilities company National Grid (NGG), which advanced 3% and 1.8%, respectively. They were followed by mining company BHP Group (BHP) and software firm Endava (DAVA), which increased 1.2% and 0.8%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and pharmaceutical company Silence Therapeutics (SLN), which lost 17% and 2.3%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which dropped 2.2% each.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10